There are contradictory explanations over the cancellation of testing of a ‘miracle’ cancer cure.
QBiotics, the Brisbane pharmaceutical company developing a promising skin cancer treatment, is at odds with the charity it had engaged to assist it with testing the drug before the trials were abruptly pulled last month.
QBiotics had planned a sharemarket float last year under then chairman Rick Holliday-Smith, the former Cochlear chair, and had been valued at some $700 million.The drug – tigilanol tiglate – was in what is known as phase 2b testing by the Melanoma Institute and Cairns Hospital, according to QBiotics.reported on the cancellation of the trial: “My understanding is we couldn’t recruit patients here; that’s where I have to leave it.
An oncologist at Cairns Hospital, Megan Lyle, who was conducting the trial, didn’t immediately respond to a request for comment. Queensland has the world’s highest rate of melanoma, according to the hospital. “Up here in Far North Queensland because we have a tropical environment, there is no shortage of people who are dealing with melanoma,” Dr Lyle said in 2020.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Man charged after teen fell to his death on Perth worksite tells court safety and management of staff not his jobA man charged over the death of a teenager at a worksite in Perth has gone on trial, arguing worker safety was not his responsibility.
Read more »
Why did Eleanor Williams frame innocent men for rape and trafficking?Psychiatrist speculated she had PTSD from childhood trauma but trial offered few clues
Read more »
‘You can blame him’: Trump shifts responsibility for January 6 on PenceEx-president’s remarks come after his former vice-president said that history will hold Trump accountable for the violence
Read more »
Asylum seekers win permission for Rwanda policy legal challengeTen people from conflict zones threatened with removal to Africa claim there has been a failure to consider risks of deportation
Read more »
Silicon Valley Bank: parent company, CEO and CFO sued amid market turmoilProposed class-action lawsuit claims bank failed to reveal how rising interest rates made it ‘particularly susceptible’ to failure
Read more »
Silicon Valley Bank: inquiries launched into bank’s collapse and UK armProbes announced in the UK and US over failure of California lender as financial markets recovered from Monday’s turmoil
Read more »